Crosspoint Capital Strategies’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-134
Closed -$5K 637
2015
Q1
$5K Buy
+134
New +$5K ﹤0.01% 455